105 related articles for article (PubMed ID: 11121706)
1. Venodilatory effect of pranidipine, a calcium channel blocker, monitored with perfluorocarbon in vivo (19)F-NMR spectroscopy.
Sogabe T; Mori T; Ohura M; Tominaga M; Koga K; Yabuuchi Y
Magn Reson Imaging; 2000 Oct; 18(8):1011-6. PubMed ID: 11121706
[TBL] [Abstract][Full Text] [Related]
2. Venodilator effects of pranidipine, a 1,4-dihydropyridine Ca2+ channel antagonist, in rats: comparison with nifedipine and amlodipine.
Hirano T; Ohura M; Orito K; Fujiki H; Miyakoda G; Mori T
Eur J Pharmacol; 1997 Apr; 324(2-3):201-4. PubMed ID: 9145772
[TBL] [Abstract][Full Text] [Related]
3. Effects of vasodilators on the signal intensity of perfluorocarbon monitored by in vivo 19F-NMR spectroscopy.
Sogabe T; Imaizumi T; Mori T; Tominaga M; Koga K; Yabuuchi Y
Magn Reson Imaging; 1997; 15(3):341-5. PubMed ID: 9201682
[TBL] [Abstract][Full Text] [Related]
4. Pranidipine, a 1,4-dihydropyridine calcium channel blocker that enhances nitric oxide-induced vascular relaxation.
Mori T; Takase H; Toide K; Hirano T; Kambe T; Nakayama N; Schwartz A
Cardiovasc Drug Rev; 2001; 19(1):1-8. PubMed ID: 11314598
[TBL] [Abstract][Full Text] [Related]
5. Pranidipine, a new 1,4-dihydropyridine calcium channel blocker, enhances cyclic GMP-independent nitric oxide-induced relaxation of the rat aorta.
Mori T; Takeuchi T; Ohura M; Miyakoda G; Fujiki H; Orito K; Yoshida K; Hirano T; Yamamura Y; Sumida T; Nakaya Y; Satake H; Hata F
Mol Cell Biochem; 1998 Jan; 178(1-2):335-43. PubMed ID: 9546618
[TBL] [Abstract][Full Text] [Related]
6. Pranidipine enhances the action of nitric oxide released from endothelial cells.
Yang J; Fukuo K; Morimoto S; Niinobu T; Suhara T; Ogihara T
Hypertension; 2000 Jan; 35(1 Pt 1):82-5. PubMed ID: 10642279
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of the potent and long-lasting antihypertensive action of the new calcium channel blocker pranidipine. Evidence for strong affinity to the calcium channels or membranes.
Miyakoda G; Nakayama N; Matsui K; Yabuuchi Y
Arzneimittelforschung; 1995 Apr; 45(4):471-5. PubMed ID: 7779144
[TBL] [Abstract][Full Text] [Related]
8. Hemodynamic effects of the calcium channel blocker pranidipine on exercise-induced angina.
Nishinaka Y; Yokota M; Watanabe M; Sobue T; Iwase M; Ukai M; Ando A; Nagata K; Saito H
Int J Clin Pharmacol Ther; 1994 Oct; 32(10):542-9. PubMed ID: 7834162
[TBL] [Abstract][Full Text] [Related]
9. Effects of pranidipine, a new calcium antagonist, on circulation in the choroid, retina and optic nerve head.
Tamaki Y; Araie M; Tomita K; Urashima H
Curr Eye Res; 1999 Sep; 19(3):241-7. PubMed ID: 10487962
[TBL] [Abstract][Full Text] [Related]
10. Effects of pranidipine, a calcium channel antagonist, in an avian model of heart failure.
Kim CS; Matsumori A; Goldberg L; Doye AA; McCoy Q; Gwathmey JK
Cardiovasc Drugs Ther; 1999 Sep; 13(5):455-63. PubMed ID: 10547227
[TBL] [Abstract][Full Text] [Related]
11. Comparative actions of dihydropyridine slow channel calcium blocking agents in conscious dogs: systemic and coronary hemodynamics with and without combined beta adrenergic blockade.
Warltier DC; Zyvoloski MG; Gross GJ; Brooks HL
J Pharmacol Exp Ther; 1984 Aug; 230(2):367-75. PubMed ID: 6146711
[TBL] [Abstract][Full Text] [Related]
12. [Effects of pranidipine (OPC-13340), a novel 1,4-dihydropyridine derivative Ca-antagonist, on isolated porcine coronary contraction and acute myocardial ischemia in the pig].
Ohura M; Mori T; Watanabe K; Ikezono K; Nakayama N; Tominaga M; Yabuuchi Y
Nihon Yakurigaku Zasshi; 1994 Mar; 103(3):101-9. PubMed ID: 8144102
[TBL] [Abstract][Full Text] [Related]
13. Effects of lomerizine, a novel Ca2+ channel blocker, on the normal and endothelin-1-disturbed circulation in the optic nerve head of rabbits.
Toriu N; Sasaoka M; Shimazawa M; Sugiyama T; Hara H
J Ocul Pharmacol Ther; 2001 Apr; 17(2):131-49. PubMed ID: 11324981
[TBL] [Abstract][Full Text] [Related]
14. Sympathoinhibitory effects of central nifedipine in spontaneously hypertensive rats on high versus regular sodium intake.
Huang BS; Leenen FH
Hypertension; 1999 Jan; 33(1):32-5. PubMed ID: 9931078
[TBL] [Abstract][Full Text] [Related]
15. Effects of calcium channel blockers and hydralazine on epinephrine-induced hyperglycemia in vivo.
Ogihara M
Jpn J Pharmacol; 1989 Jun; 50(2):141-7. PubMed ID: 2770052
[TBL] [Abstract][Full Text] [Related]
16. Effects of the new long-acting dihydropyridine calcium antagonist pranidipine on the endothelium-dependent relaxation in isolated rat aorta in vitro.
Nakayama N; Ikezono K; Ohura M; Yabuuchi Y
Arzneimittelforschung; 1993 Dec; 43(12):1266-70. PubMed ID: 8141812
[TBL] [Abstract][Full Text] [Related]
17. [Vasodilator effects of LF 2.0254, a new 1,4-dihydropyridine. Comparison with nifedipine].
Pruneau D; Roy F; Brown NL
Therapie; 1989; 44(3):203-8. PubMed ID: 2781506
[TBL] [Abstract][Full Text] [Related]
18. In vivo receptor occupancy and plasma concentration of pranidipine, a potent and long-acting dihydropyridine calcium antagonist.
Yamada S; Uchida S; Urayama A; Kimura R
Pharmacology; 1999 Oct; 59(4):171-82. PubMed ID: 10474077
[TBL] [Abstract][Full Text] [Related]
19. Prolonged inhibition of vascular contraction and calcium influx by the novel 1,4-dihydropyridine calcium antagonist cinaldipine (FRC-8653).
Yoshimoto R; Dohmoto H; Yamada K; Goto A
Jpn J Pharmacol; 1991 Jun; 56(2):225-9. PubMed ID: 1881002
[TBL] [Abstract][Full Text] [Related]
20. Natriuretic action of manidipine hydrochloride, a new calcium channel blocker, in spontaneously hypertensive rats.
Nagaoka A; Shibota M
Jpn J Pharmacol; 1989 Oct; 51(2):299-301. PubMed ID: 2593386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
